Growth kinetics, self‐renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation

Recent studies have demonstrated the existence of a subset of cells in human bone marrow capable of differentiating along multiple mesenchymal lineages. Not only do these mesenchymal stem cells (MSCs) possess multilineage developmental potential, but they may be cultured ex vivo for many passages without overt expression of a differentiated phenotype. The goals of the current study were to determine the growth kinetics, self‐renewing capacity, and the osteogenic potential of purified MSCs during extensive subcultivation and following cryopreservation. Primary cultures of MSCs were established from normal iliac crest bone marrow aspirates, an aliquot was cryopreserved and thawed, and then both frozen and unfrozen populations were subcultivated in parallel for as many as 15 passages. Cells derived from each passage were assayed for their kinetics of growth and their osteogenic potential in response to an osteoinductive medium containing dexamethasone. Spindle‐shaped human MSCs in primary culture exhibit a lag phase of growth, followed by a log phase, finally resulting in a growth plateau state. Passaged cultures proceed through the same stages, however, the rate of growth in log phase and the final number of cells after a fixed period in culture diminishes as a function of continued passaging. The average number of population doublings for marrow‐derived adult human MSCs was determined to be 38 ± 4, at which time the cells finally became very broad and flattened before degenerating. The osteogenic potential of cells was conserved throughout every passage as evidenced by the significant increase in APase activity and formation of mineralized nodular aggregates. Furthermore, the process of cryopreserving and thawing the cells had no effect on either their growth or osteogenic differentiation. Importantly, these studies demonstrate that replicative senescence of MSCs is not a state of terminal differentiation since these cells remain capable of progressing through the osteogenic lineage. The use of population doubling potential as a measure of biological age suggests that MSCs are intermediately between embryonic and adult tissues, and as such, may provide an in situ source for mesenchymal progenitor cells throughout an adult's lifetime. J. Cell. Biochem. 64:278–294. © 1997 Wiley‐Liss, Inc.

[1]  L. Hayflick Antecedents of cell aging research , 1989, Experimental Gerontology.

[2]  Ihor R. Lemischka,et al.  Developmental potential and dynamic behavior of hematopoietic stem cells , 1986, Cell.

[3]  C. McCulloch,et al.  Effects of donor age on osteogenic cells of rat bone marrow in vitro , 1990, Mechanisms of Ageing and Development.

[4]  W. Stein,et al.  Kinetics of in vitro ageing of mouse embryo fibroblasts. , 1984, Journal of cell science.

[5]  P. Néve,et al.  The number of fibroblastic colonies formed from bone marrow is decreased and the in vitro proliferation rate of trabecular bone cells increased in aged rats. , 1992, Bone.

[6]  H. Gruber,et al.  Age‐related changes in osteogenic stem cells in mice , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  L. Hayflick THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.

[8]  S. Bruder,et al.  Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro , 1997, Journal of cellular biochemistry.

[9]  E. Levine,et al.  Human endothelial cells: use of heparin in cloning and long-term serial cultivation. , 1983, Science.

[10]  S. Bruder,et al.  Mesenchymal stem cells in bone development, bone repair, and skeletal regenaration therapy , 1994 .

[11]  A I Caplan,et al.  Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. , 1995, Bone marrow transplantation.

[12]  F. Watt,et al.  Stem cells: the generation and maintenance of cellular diversity. , 1989, Development.

[13]  M. Owen Marrow stromal stem cells , 1988, Journal of Cell Science.

[14]  J. R. Smith,et al.  Intraclonal variation in proliferative potential of human diploid fibroblasts: stochastic mechanism for cellular aging. , 1980, Science.

[15]  Su‐Li Cheng,et al.  Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. , 1994, Endocrinology.

[16]  A. Caplan,et al.  Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5‐azacytidine , 1995, Muscle & nerve.

[17]  T. Norwood,et al.  Clonal selection, attenuation and differentiation in an in vitro model of hyperplasia. , 1974, The American journal of pathology.

[18]  M. Eden,et al.  Loss of division potential in culture: aging or differentiation? , 1980, Science.

[19]  J. Smith,et al.  Mesenchymal stem cells reside within the connective tissues of many organs , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[20]  B. Riggs,et al.  Isolation and characterization of osteoblast precursor cells from human bone marrow , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  R. Sager Tumor suppressor genes: the puzzle and the promise. , 1989, Science.

[22]  A I Caplan,et al.  A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. , 1995, Experimental cell research.

[23]  A. Caplan,et al.  Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of a H‐2Kb‐tsA58 transgenic mouse , 1996, Journal of cellular physiology.

[24]  L. Szilard ON THE NATURE OF THE AGING PROCESS. , 1959, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Green,et al.  Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is , 1975, Cell.

[26]  L. Sachs The molecular control of blood cell development. , 1987, Science.

[27]  L. Avioli,et al.  Bone deficit in ovariectomized rats. Functional contribution of the marrow stromal cell population and the effect of oral dihydrotachysterol treatment. , 1986, The Journal of clinical investigation.

[28]  G. Verdonk,et al.  In vitro aging of human bone marrow derived stromal cells , 1981, Mechanisms of Ageing and Development.

[29]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[30]  J. R. Smith,et al.  Colony size distributions as a measure of in vivo and in vitro aging. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Epstein,et al.  Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. , 1970, Laboratory investigation; a journal of technical methods and pathology.

[32]  L. Hayflick,et al.  The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.

[33]  E. Schneider,et al.  Characterization of fractionated human diploid fibroblast cell populations. , 1976, Experimental cell research.

[34]  E. Pfendt,et al.  DNA synthesis in the human diploid cell strain WI-38 during in vitro aging: an autoradiography study. , 1979, Journal of gerontology.

[35]  C. Devlin,et al.  The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. , 1994, Archives of oral biology.

[36]  A. Caplan,et al.  Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. , 1992, Bone.

[37]  I. Weissman,et al.  Purification and characterization of mouse hematopoietic stem cells. , 1988, Science.

[38]  A. Malmström,et al.  Proliferation of cultured fibroblasts is inhibited by L‐Iduronate—containing glycosaminoglycans , 1991, Journal of cellular physiology.

[39]  A. Caplan,et al.  Myogenic Expression of Mesenchymal Stem Cells within Myotubes of mdx Mice in Vitro and in Vivo. , 1995, Tissue engineering.

[40]  A I Caplan,et al.  Cytokine expression by human marrow‐derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL‐1α , 1996, Journal of cellular physiology.

[41]  E. Wang,et al.  Control of fibroblast senescence and activation of programmed cell death , 1994, Journal of cellular biochemistry.

[42]  A I Caplan,et al.  Characterization of cells with osteogenic potential from human marrow. , 1992, Bone.

[43]  H. E. Young,et al.  Cryopreservation of embryonic chick myogenic lineage-committed stem cells , 1991 .

[44]  L. Orgel,et al.  Ageing of Clones of Mammalian Cells , 1973, Nature.